In today's rapidly evolving field of biomanufacturing, traditional methods often fall short of the rigorous demands for real-time data and consistent product quality. Laser Force Cytology (LFC) has emerged as an innovative, label-free technology that offers a transformative approach to
In recent developments, Celltrion USA has significantly expanded the availability of its subcutaneous treatment for Crohn's disease and ulcerative colitis, Zymfentra, now accessible to 26 million patients across the United States. This milestone achievement is a result of the company’s strategic
Sterling Pharma Solutions is significantly expanding its GMP antibody-drug conjugate (ADC) manufacturing capacity with a £10 million investment aimed at doubling the current capacity at its Deeside, UK site. This expansion involves commissioning a new 2,300-square-foot suite, which includes a
MilliporeSigma has announced a substantial $76 million investment to expand its Bioconjugation Center of Excellence in St. Louis, Missouri, aiming to triple its current capacity for Antibody-Drug Conjugates (ADCs). This significant expansion will encompass upgrading 34,000 square feet of existing
Ardena, a prominent Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical sector, is expanding its Bioanalytical Services in the Netherlands in a substantial way. The company's latest strategic initiatives involve establishing a state-of-the-art bioanalytical laboratory
Abzena, a contract development and manufacturing organization (CDMO) specializing in complex biologics and bioconjugates, has announced an expansion of its quality control (QC) testing capabilities with a new microbiology lab in San Diego. The new facility is dedicated to enhancing analytical
